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1. Introduction
Major reductions in HIV-associated mortality have occurred
largely due to the global scale-up of antiretroviral therapy (ART).
However, evidence is emerging that patients receiving ART are at
an increased risk of age-related non-AIDS morbidity and mortality
compared with HIV-seronegative individuals (Deeks, 2009;
Guaraldi et al., 2011; Lohse et al., 2007). Several of these conditions
are classically associated with the normal ageing process but
appear to occur at an earlier age in HIV-infected persons compared
to age-matched HIV-seronegative individuals. It is possible that
not only are HIV cohorts ageing chronologically, but they may also
be undergoing accelerated biological ageing.
Chronological age is an imprecise measure of biological ageing,
due to inter-individual differences in rates of ageing. The
disconnection between chronological age and lifespan has led to
a search for effective and validated biomarkers of ageing (BoA),
deﬁned as ‘‘biological parameters of an organism that either alone
or in some multivariate composite will better predict functional
capability at some late age than will chronological age’’(Baker and
Sprott, 1988). In HIV infection, heightened inﬂammation and
immune dysfunction are likely to play a role in accelerated ageing
(Deeks, 2009). This has stimulated epidemiological assessment of
several biomarkers of inﬂammation and immune dysfunction,
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HIV-infected individuals have an increased risk of age-related morbidity despite antiretroviral treatment
(ART). Several anatomic and functional ophthalmological parameters are associated with increasing
chronological age. These may, therefore, potentially serve as biomarkers of ageing. We investigated
associations between ocular parameters (lens density, retinal vessel calibre, corneal endothelium and
retinal nerve ﬁbre layer thickness) and two ‘cellular’ biomarkers of ageing (leukocyte telomere length
and CDKN2A expression) and with frailty in a cross-sectional study of 216 HIV-infected individuals. All
ocular parameters, telomere length and frailty were associated with chronological age, whereas CDKN2A
expression was not. Retinal venular calibre and lens density were associated with shorter telomere
length (p-trend = 0.04, and 0.08, respectively), whereas CDKN2A expression and frailty status were not
associated with ocular parameters. Longitudinal studies are warranted to assess the integration of retinal
vascular calibre and lens density with systemic markers to develop an overall index of biological ageing
in HIV infection.
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including C-reactive protein (CRP), interleukin-6 (IL-6) and D-
dimer and their associations with age-related morbidity and HIV
infection (Nixon and Landay, 2010).
Only two validated BoA, telomere length (TL) and CDKN2A
expression, have so far been found to satisfy the majority of the
criteria proposed by Baker and Sprott (1988). Telomeres are
nucleoprotein complexes at the ends of eukaryotic chromosomes.
Their DNA component shortens with somatic cell division and
upon reaching a critically short length, a DNA damage signal leads
to growth cycle arrest, resulting in replicative senescence
(Saretzki and Von Zglinicki, 2002; von Zglinicki, 2002). Telomere
shortening is associated with increasing chronological age and
several pathologies. Telomere length (TL) may be useful as a
composite measure of healthy ageing, but not as a BoA when used
in isolation (Der et al., 2012; von Zglinicki, 2012). Expression
levels of the cell cycle regulator CDKN2A may represent a more
robust BoA in healthy ageing (Shiels, 2010). CDKN2A acts as a
tumour suppressor and maintains cells in a state of growth arrest,
both in replicative and stress induced-senescence. Increasing
levels of CDKN2A transcriptional expression occur with increas-
ing age and decreasing function of solid organs and peripheral
blood leucocytes (PBLs) (Koppelstaetter et al., 2008; Krishna-
murthy et al., 2004; Liu et al., 2009; McGlynn et al., 2009).
However, in disease or pro-inﬂammatory states such as HIV
infection, evaluation of CDKN2A expression may be compromised
by mechanisms such as stress-induced premature senescence
(SIPS) (Shay and Wright, 2000). Furthermore, measurement of
telomere length may be affected by the use of nucleoside reverse
transcriptase inhibitors (NRTIs) (Yamaguchi et al., 2001). Thus,
novel biomarkers are required to evaluate biological ageing in HIV
infection (Lundgren et al., 2010).
Certain anatomic and functional parameters of the eye change
with increasing chronological age. They may, therefore, serve as
potential biomarkers of ageing (Pathai et al., 2013e). We have
reported on ocular parameters related to the accelerated ageing
phenotype in HIV, including retinal vessel calibre, objective
measurement of lens density and assessment of the corneal
endothelium (Pathai et al., 2012, 2013c,d). Furthermore, we
have shown frailty to be part of this phenotype (Pathai et al.,
2013a). Frailty is a functional state characterised by an increased
risk of multiple pathologies, low physical activity and slow
motor performance (Fried et al., 2001). Frailty predicts cognitive
and physical decline and is associated with an increased risk of
morbidity and mortality, and may therefore act as a ‘clinical’
biomarker of ageing (Fried et al., 2001). There are limited data
on how these parameters correlate with cellular BoA in the
context of HIV as such markers are typically used in the
evaluation of healthy biological ageing. In addition, there are
few data relating to biological ageing in sub-Saharan Africa, a
region where the population of HIV-infected elderly people is
rapidly expanding and where the AIDS epidemic is most severe
(Mills et al., 2011).
With the need for novel BoA that could be valid in disease as
well as health, the aim of this study was to investigate the
association between eye parameters, frailty and cellular BoA in HIV
infection.
2. Methods
2.1. Study population
HIV-infected individuals aged  30 years from a community
HIV treatment clinic in a township of Cape Town, South Africa
(Hannan Crusaid Centre, Gugulethu) were recruited as HIV-
infected ‘cases’ as part of a case-control study investigating HIV
and ageing (Pathai et al., 2012, 2013a). Participants in this study
were receiving ART at the time of enrolment. Socio-demographic
information and medical history were obtained by interviewing
participants in their ﬁrst language (Xhosa or English). Data
collected included factors known to affect ageing (e.g. UV
exposure, smoking history). All participants underwent a full
ophthalmic examination including measurement of visual
acuity, evaluation by slit lamp microscopy and indirect
ophthalmoscopy.
The study was approved by the Ethics Committees of the
London School of Hygiene and Tropical Medicine and the
University of Cape Town Faculty of Health Sciences, and adhered
to the tenets of the Declaration of Helsinki. Written informed
consent was obtained from all participants.
2.2. Anthropometry, blood pressure and physical function including
frailty assessment
Blood pressure (BP) was measured with a digital sphygmoma-
nometer. Mean arterial blood pressure (MABP) was deﬁned as two-
thirds of the diastolic plus one-third of the systolic BP (Wong et al.,
2003). Hypertension was deﬁned as a systolic BP of 140 mmHg or
higher, diastolic BP of 90 mmHg or higher, or the combination of
self-reported high BP diagnosis and the use of anti-hypertensive
medications (Wong et al., 2005). Body mass index (BMI) was
deﬁned as weight (in kilograms)/height2.
Physical frailty was deﬁned by the presence of 3 of 5 criteria:
(i) unintentional weight loss (self reported and veriﬁed from clinic
records where possible) (ii) self-reported low physical activity, (iii)
self-reported exhaustion, (iv) weak grip strength and (v) slow
walking time. Pre-frailty was deﬁned as the presence of one or two
of these criteria. Detailed information is available in the
Supplementary Methods.
3. Blood-based biomarkers
3.1. DNA/RNA extraction
DNA was extracted from PBLs using the MaxwellTM Automated
Puriﬁcation System according to manufacturer’s instructions
(Promega, USA). DNA concentration and purity were quantiﬁed
by Nanodrop Spectrophotometer (ThermoFisher Scientiﬁc, USA).
RNA was extracted using Trizol reagent (Invitrogen, UK) following
manufacturer’s guidelines. DNA/RNA extraction was performed in
Cape Town and samples shipped on dry ice to the University of
Glasgow.
3.1.1. Telomere length determination
TL were determined by QPCR following the method of Cawthon
(2002). TL determination was performed blindly using a Roche
Light Cycler LC480. Brieﬂy, telomere length analyses were
performed in triplicate for each sample, using a single-copy gene
amplicon primer set (acidic ribosomal phosphoprotein, 36B4) and
a telomere-speciﬁc amplicon primer set (Koppelstaetter et al.,
2008). Refer to Supplementary Methods for further detail.
3.1.2. CDKN2A expression determination
Relative quantitative real-time PCR (qRT-PCR) was used to
estimate mRNA levels corresponding to the candidate senescence
associated gene – CDKN2A. Expression levels were measured
against a reference hypoxanthine phosphoribosyltransferase
(HPRT) housekeeping gene on an ABI Prism(R) 7500 Sequence
Detection System. Sequences of human TaqManTM Primer/Probe
sets were designed by Primer Express algorithm (Applied
Biosystems, Austin, TX, USA). The comparative threshold cycle
method (DDCT)(Livak and Schmittgen, 2001) was employed to
quantify relative gene expression.
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4. Ocular biomarkers
The following four ocular parameters were selected (Table 1).
Detailed methods are supplied in the Supplementary Methods.
(i) Lens density: Pentacam imaging (Oculus, Wetzlar, Germany)
was used to obtain ‘‘Scheimpﬂug images’’ of the lens and an
objective estimate of lens density on a continuous scale. Lens
density increases with increasing chronological age.
(ii) Retinal vessel calibre: Participants had stereoscopic 308 colour
retinal photographs taken under pharmacological pupil
dilation with a fundus camera (CF-2; Canon Inc., Tokyo,
Japan). Vessel calibre indices were determined in a semi-
automated manner using the IVAN computer program
(Singapore Eye Research Institute, Singapore) and a standard-
ized protocol described previously (Wong et al., 2004).
Narrowing of retinal arterioles is associated with increasing
chronological age (Leung et al., 2003; Wong et al., 2003).
(iii) Corneal endothelial cell parameters: A non-contact specular
microscope was used (SP02, CSO, Florence, Italy). The
operator focused and aligned a real-time image of the
participant’s eye. Endothelial cell parameters were automat-
ically calculated from this image by the microscope software.
Endothelial cell density (ECD) decreases with age, whereas
the change in cell size (coefﬁcient of variation) increases with
age. The proportion of cells with six sides (hexagonality
index) decreases with age.
(iv) Retinal nerve ﬁbre layer (RNFL): measured using Spectral
OCT/SLO optical coherence tomography (Opko/OTI Inc.,
Miami, FL) which uses a scanning laser diode of 830 nm to
provide images of ocular microstructures. A peri-papillary
(around optic nerve head) protocol inbuilt in the software was
used to determine the average and quadrant-speciﬁc RNFL
thickness (superior, inferior, temporal and nasal). The RNFL
becomes thinner with increasing age (Chi et al., 1995;
Kanamori et al., 2003).
5. Statistical analysis
One eye was randomly selected for analysis. Where an eye was
not available, for example due to trauma or corneal opacity, the
contralateral eye was used. Analyses were performed using Stata
12 (Stata Corp., College Station, TX). Clinical and biological data
were summarized as the median with interquartile range (IQR) or
mean with standard error (SE), as appropriate. Analyses were
conducted on log10-transformed values of telomere length and
mean CDKN2A expression to satisfy the assumption of normally
distributed residuals. Results are displayed back-transformed to
the original scale. Validation of the biomarkers was performed
using linear regression models with age in years as a continuous or
categorical variable. Ocular biomarker measurements were
divided into quartiles. Univariable linear regression was per-
formed to compare the quartiles of ocular parameters with mean
telomere length and CDKN2A expression and frailty status
respectively. Multivariable linear regression models were used
to examine the relationships of telomere length, CDKN2A
expression as the respective dependent variable with ocular
biomarker quartiles and frailty status and explanatory variables
(age group [30–39; 40–49; >50 years], gender, MABP; BMI,
smoking, UV exposure, current and nadir CD4 count, peak and
current HIV viral load) as independent variables. Marginal
adjusted means for telomere length and CDKN2A expression
were estimated at the mean value of covariates in the model. The
Wald test was used to assess statistical signiﬁcance of the
association of each ocular parameter on systemic biomarker
levels.
6. Results
6.1. Participant characteristics and biomarker distributions
216 participants underwent assessment. The median age was
40 years (IQR: 35–46) and 25% (n = 54) were male. Characteristics
of the participants by gender are given in Supplementary Table S1.
Women reported less alcohol consumption and cigarette use
compared to men (p < 0.0001 for both). Men had lower BMI and
lower current CD4 counts (p < 0.0001 and p = 0.04, respectively).
The number of participants providing data for each parameter
varied, as not every participant was able to complete all
ophthalmic tests or had a blood sample available for analysis.
Summary statistics for each biomarker, stratiﬁed by gender and
age group are displayed in Supplementary Table S2. For the
Table 1
Biomarkers of aging, methods of measurement and the impact of aging.
Anatomical site Parameter Method of measurement Age-related changes
Peripheral blood leukocytes Telomere length (TL) qPCR TL shortens
CDKN2A expression qRT-PCR to estimate mRNA levels Increased expression
Corneal endothelium Endothelial cell density (ECD) Specular microscopy Decreased ECD
Coefﬁcient of variation (CV) Increased CV
Hexagonality index (Ex) Decreased Ex
Lens Lens opacity Pentacam-lens densitometry
Linear value
Peak All increase
3-D average
Retina Retinal nerve ﬁbre layer (RNFL) thickness Optical coherence tomography (OCT) Thinner RNFL – all quadrants
(Average, superior, inferior, nasal,
temporal quadrants)
Semi-automated retinal analysis
software applied to fundus photographs
Reduced diameter of arterioles
and arterio-venous ratio (AVR)
Retinal vessel caliber
Systemic Frailty status
Non-frail (no criteria) Assessment of walking speed, grip strength,
self-report of weight loss, exhaustion
and low physical activity
Pre-frail (1–2 criteria) Frailty status increases
Frail: 3 of 5 criteria
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majority of biomarkers, there was no evidence of gender
differences; however for endothelial cell parameters, the cell
density was greater in women compared to men, and women were
more frail than men (p = 0.03 for both).
6.2. Validation of biomarkers against chronological age
All biomarkers were initially validated against chronological
age in a HIV-seronegative control group of similar age and gender,
recruited as part of a case-control study (Pathai et al., 2013b).
Assessment within this HIV-infected study population was
subsequently performed (Supplementary Table S3). Telomere
length was associated with chronological age (p = 0.03), however
CDKN2A expression was not (p = 0.25). All ocular parameters
except the RNFL nasal quadrant and hexagonality index of
endothelial cells were associated with chronological age, therefore
these ocular parameters were not analysed further. The association
of the prospective biomarkers with chronological age is presented
in Supplementary Figures 1a–o. The R-squared values of the
regressions against chronological age were highest for lens density
parameters (linear lens density R2 = 0.63). All analyses thereafter
were adjusted for age, gender and other possible confounding
variables related to the parameter of interest.
6.3. Association of ocular parameters with blood-based biomarkers
Shorter telomere length was associated with increasing retinal
venular diameter (p-trend = 0.04) – Table 2. Telomere length was
not related to retinal arteriolar diameter. Table 3 reports
associations with lens density: there was a trend of shorter
telomere length with increasing lens density (p-trend = 0.08).
Endothelial cell parameters and RNFL thickness were not related to
TL or CDKN2A expression (data not shown).
6.4. Association of frailty status with blood-based and ocular
biomarkers
There was no association of frailty status with either telomere
length or CDKN2A expression (p = 0.54 and p = 0.76, respectively).
Similarly, none of the ocular parameters were associated with
frailty (data not shown).
7. Discussion
We compared several ocular parameters and frailty, a clinical
correlate of ageing, with TL and CDKN2A expression as established
and validated biomarkers of ageing. Retinal venular diameter was
the most informative ocular biomarker, showing increased venular
diameter with decreasing TL. Objective measurement of lens
density also showed a strong trend of decreasing TL with
increasing lens density. In contrast, CDKN2A expression, a
validated biomarker of ageing in health, was not associated with
frailty or any of the ocular parameters. These ﬁndings suggest that
the ocular lens and retinal vasculature, which reﬂect different
physiological systems, may have a role to play in the determination
of biological age and ageing trajectories in HIV infection, which
may differ from that seen in physiological ‘healthy ageing’.
We have already established in this same study population that
HIV infection is associated with increased frailty (Pathai et al.,
2013a), changes in retinal vessel calibre, lens density and in
corneal endothelial cells that are consistent with accelerated
ageing (Pathai et al., 2012, 2013c,d). These ﬁndings of an HIV-
related accelerated ageing phenotype, suggest there will be
important clinical and health systems implications as HIV-infected
populations continue to increase and live longer. Associations of
these ocular and clinical parameters with validated BoA have not
been investigated to date. The need for evaluated biomarkers in
determining biological age is gaining increasing importance as
data emerge about the excess risk of age-related morbidity in HIV-
infected individuals despite suppression of viral load (Lundgren
et al., 2010).
Of a wide range of BoA evaluated, only TL and CDKN2A are
thought to meet the Baker and Sprott criteria (Baker and Sprott,
1988). The majority of putative BoA assessed fail on the basis that
they are unable to predict functional capacity in the absence of
disease (Simm et al., 2008b). The issue is further compounded in
HIV infection as BoA are typically used to evaluate physiological,
‘healthy’ ageing. Measurement of ‘accelerated’ biological ageing
HIV infection may involve different mechanisms, and therefore
render some BoA invalid in their measurement. This is pertinent to
the lack of association between CDKN2A and chronological age in
our HIV-infected study population, where the disease state
decouples CDKN2A expression from correlation with chronological
ageing. We have found CDKN2A expression to be signiﬁcantly
higher in HIV-infected individuals compared to age- and gender-
matched controls (Pathai et al., unpublished data). However, as
well as functioning as a tumour suppressor, CDKN2A is also a
component of stress-induced premature senescence (SIPS) (Shay
and Wright, 2000) which prevents T-cell replication following
acute insult (Liu et al., 2011). The decoupling of the relationship
Table 2
Association of retinal arteriolar and venular diameter with systemic biomarkers.
Vessel parameter N TL P N CDKN2A P
Rel T/S Mean
Retinal arteriolar quartiles (mm)
1st 38 0.89 37 0.37
(113.16–150.13) (0.81–0.97) (0.29–0.47)
2nd 42 0.87 40 0.54
(150.56–161.06) (0.80–0.95) (0.43–0.68)
3rd 62 0.92 61 0.43
(161.53–171.89) (0.87–0.99) (0.36–0.51)
4th 54 0.93 p-trend 53 0.44
(172.79–207.80) (0.87–1.00) 0.25 (0.36–0.54) 0.19
Retinal venular quartiles (mm)
1st 66 1.04 64 0.54
(218.31–258.35) (0.92–1.17) (0.39–0.74)
2nd 57 0.89 56 0.41
(258.78–269.99) (0.83–0.95) (0.34–0.49)
3rd 40 0.87 40 0.48
(270.24–281.54) (0.79–0.97) (0.36–0.63)
4th 33 0.74 p-trend 31 0.31
(281.7–326.08) (0.63–0.86) 0.04 (0.20–0.51) 0.15
Adjusted for age, gender, smoking, BMI, hypertension and venular/arteriolar retinal
calibre (where appropriate) and HIV-related co-variates (current and nadir CD4
count, current and peak viral load, ART duration and ART type).
Table 3
Association of lens density with systemic biomarkers, n = 198.
Lens densitya N TL P N CDKN2A P
Rel T/S Mean
Linear quartiles
1st 48 0.95 47 0.42
(7.5–9.2) (0.87–1.03) (0.33–0.55)
2nd 54 0.97 53 0.45
(9.25–9.8) (0.90–1.04) (0.37–0.55)
3rd 48 0.87 48 0.44
(9.85–10.7) (0.81–0.94) (0.36–0.55)
4th 48 0.84 p-trend 46 0.48 0.94
(10.8–13.9) (0.77–0.93) 0.08 (0.36–0.62)
Adjusted for age, gender, smoking, UV exposure and HIV-related parameters
(current and nadir CD4 count, current and peak viral load, ART duration and ART
type).
a Measured on a continuous scale 0–100, 100 being an opaque (completely
dense) lens 4th quartile denotes aged phenotype.
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between CDKN2A expression and chronological age in HIV infected
individuals is a direct consequence of HIV-associated premature T-
cell senescence (Deeks, 2011), and lack of further T cell replication
with HIV infection. SIPS causes populations of cells to ‘freeze’ in
time with respect to age, confounding the determination of rate
changes in replicative senescence and therefore biological ageing.
The Baker and Sprott criteria state ‘‘The biomarker should reﬂect
some basic biological process of ageing and certainly not the
predisposition toward a disease state or some error in metabolism’’
(Baker and Sprott, 1988). Thus, the induction of SIPS by CDKN2A in
disease states such as HIV infection suggests that this is an
unreliable BoA in these circumstances.
Telomere length has also been shown to be signiﬁcantly shorter
in HIV-infected individuals compared to HIV-seronegative controls
in this population (Pathai et al., unpublished data), and may better
satisfy the Baker and Sprott criteria in disease states. However,
telomere attrition is affected by psychosocial confounders,
genetics and potentially by NRTIs used in the treatment of HIV
infection (Yamaguchi et al., 2001), leading to the suggestion TL
may be useful as a composite measure of healthy ageing, but not as
a BoA when used in isolation (Der et al., 2012; von Zglinicki, 2012).
The trend of increasing lens density with shortening of telomere
length is intuitive, and the strong association of lens density with
chronological age (when compared to TL), suggests that in this
population, lens density may be an attractive BoA as it is less
susceptible to changes caused by systemic disease states. Logistical
constraints precluded assessment of telomere length in T-cell
subsets, which has been advocated in the context of HIV infection
(Aviv et al., 2006). While we acknowledge that this would give a
higher resolution data set, the primary aim of this study was to
provide preliminary data to inform future work and assessment of
telomere length in PBLs has been the approach used by others in
this ﬁeld (Leeansyah et al., 2013; Malan-Muller et al., 2013). It is
also important to consider the role of ART, particularly NRTIs, in the
context of accelerating mitochondrial ageing (Smith et al., 2012).
For example, NRTIs may accelerate aspects of intrinsic biological
ageing via clonal expansion of mtDNA mutations (Payne et al.,
2011). HIV and/or HAART exposure are also associated with
increased prevalence of AC/TG mtDNA mutations in mothers and
show a similar tendency in infants exposed during pregnancy
(Jitratkosol et al., 2012). This suggests that mtDNA mutations may
affect the ageing trajectories of HIV and ART-exposed populations.
The frailty phenotype was initially described in HIV-infected
individuals in 2007. In this study the prevalence of frailty among
55-year-old men infected with HIV for 4 years was similar to that
of uninfected men  65 years old (Desquilbet et al., 2007).
Similarly, we have found an increased prevalence of frailty in this
study population (Pathai et al., 2013a). However, we did not detect
an association between frailty and cellular BoA or ocular
parameters. In contrast, in an HIV-seronegative study population
from the same community we found increasing lens density to be
associated with frailty status (Pathai et al., unpublished data). This
suggests that the frailty phenotype in HIV, while sharing some
characteristics with the original description in the geriatric
population (Fried et al., 2001), has other characteristics perhaps
unique to HIV infection and/or use of ART. This is corroborated by
the ﬁnding that CD4 count is also associated with the development
of frailty (Desquilbet et al., 2009; Pathai et al., 2013a), suggesting
that compromise of the immune system in HIV-infected individu-
als contributes to the development of the frailty phenotype.
Furthermore, HIV-infected frail individuals have higher concen-
trations of pro-inﬂammatory cytokines such as IL-6, and tumour
necrosis factor-alpha (TNF-a), and C-reactive protein (Margolick
et al., 2012). Age-related comorbidities and AIDS predict conver-
sion from being non-frail to frail, and having a persistent frailty-
like phenotype before ART initiation also predicts mortality
(Desquilbet et al., 2011). Collectively, these ﬁndings suggest that
frailty in HIV infection is not simply an accelerated version of
geriatric frailty, and so the lack of relationship with BoA at a
cellular or ocular level may be expected.
Retinal arteriolar and venular calibre typically narrow with
increasing chronological age (Leung et al., 2003; Wong et al., 2003),
thus shortening of TL might be expected to be associated with
narrowing of venular diameter. However, our observation that
shortened TL was associated with increasing retinal venular
diameter is nevertheless plausible in the context of HIV infection.
Inﬂammation is recognised as a key pathogenic process in HIV
infection, and also in HIV-related accelerated ageing (Deeks, 2009).
Larger retinal venular calibre is associated with systemic
inﬂammatory markers such as CRP, ﬁbrinogen, IL-6 and smoking,
independently of age (Ikram et al., 2004; Klein et al., 2006; Wong
et al., 2006). This suggests that the heightened inﬂammatory
processes observed in HIV infection are consistent with a
biologically aged phenotype as manifest by shorter TL. Patients
with HIV infection are at increased risk of cardiovascular disease
(Triant, 2012). Although factors potentially contributing to this
elevated risk include traditional cardiovascular risk factors and
antiretroviral medications, it is likely that inﬂammatory and
immunologic factors also contribute. Vascular endothelial dys-
function is also associated with larger retinal venules independent
of traditional cardiovascular risk factors (Nguyen et al., 2010). We
therefore postulate that HIV-related inﬂammation and/or endo-
thelial dysfunction manifests as retinal venular dilation and
contributes to the biologically aged phenotype. Furthermore,
retinal arteriolar narrowing which is associated with increased
cardiovascular risk (Wong et al., 2002), is related to increasing
duration of ART, independent of age (Pathai et al., 2012). Thus,
assessment of retinal vessel diameters may be a novel and non-
invasive method of assessing vascular risk and biological ageing in
this population.
This study has some limitations. The gender composition of
participants was three-quarters female, however this is reﬂective
of the HIV epidemic in Africa. There were also differences between
genders (smoking, alcohol consumption) that may truly exist or
may have been misclassiﬁed (e.g. misreporting true smoking
habits) and this could have confounded associations of the ocular
parameters with the other biomarkers. Participants were recruited
from a community of considerable socio-economic deprivation,
and therefore likely to have been exposed to factors known to
increase biological ageing such as high UV exposure from outdoor
work. Therefore, our data might over-estimate associations related
to ageing. Lastly, as study participants are of African ancestry, our
results are generalizable to the African population.
Biomarkers are used extensively in the assessment of HIV
infection, from monitoring of CD4 count and HIV RNA viral load to
assess response to ART, to the use of indices such as the (Veterans
Aging Cohort Study) VACS Index to predict morbidity and mortality
(Justice et al., 2012). Candidate biomarkers of ageing have been
proposed in HIV-uninfected elderly population cohorts in other
settings, as well as their relationship with frailty e.g. the Newcastle
85+ study (Collerton et al., 2012; Martin-Ruiz et al., 2011).
Longitudinal studies in different populations are needed to assess
how ocular parameters change over time in relation to blood-based
biomarkers and to other candidate biomarkers that have been
previously evaluated (Martin-Ruiz et al., 2011; Simm et al., 2008a).
Our ﬁndings indicate that measurement of biological ageing in HIV
infection may be complicated by inﬂammation and immune
dysfunction such that BoA validated in healthy ageing are no
longer accurate predictors. This suggests that other biomarkers are
needed; our data indicate that measurement of lens density and
retinal vessel calibre may be useful additions in the assessment of
biological ageing. We have proposed a research agenda to further
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deﬁne and validate ocular biomarkers of ageing (Pathai et al.,
2013e). Vessel calibre assessment may provide information about
inﬂammation and systemic vascular changes, whereas lens density
evaluation may be indicative of true biological ageing. Longitudinal
studies are warranted to assess the integration of these data with
systemic markers to develop an overall estimate of biological
ageing and possibly mortality risk. In conclusion, the eye may
prove to be a useful addition in the assessment of biological ageing
and to improve our understanding of HIV-related accelerated
ageing.
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